Literature DB >> 17093403

Mutational analysis of RPGR and RP2 genes in Japanese patients with retinitis pigmentosa: identification of four mutations.

Zi-Bing Jin1, Xiao-Qiang Liu, Mutsuko Hayakawa, Akira Murakami, Nobuhisa Nao-i.   

Abstract

PURPOSE: To identify mutations in RPGR and RP2 genes in a series of Japanese retinitis pigmentosa (RP) families and to determine the association between the phenotypic changes in patients/carriers and the mutations.
METHODS: A total of 37 unrelated RP families were recruited, three of which were with typical X-linked RP (XLRP), and other 34 families included 29 multiplex families and 5 simplex RP cases with no family history of RP. In addition, At least one RP patient had myopia >-3.0D in these families. RPGR and RP2 genes were comprehensively screened by using the direct polymerase chain reaction-sequencing method. Detailed phenotypes of the families with confirmed mutations were assessed by routine ophthalmic examinations, Goldmann perimetry, electroretinography and color fundus photography.
RESULTS: Four mutations in RPGR and RP2 genes were identified. Of the three XLRP families, one had an ORF15 mutation and another had an RP2 mutation. Two ORF15 mutations were found in three of the other 34 RP families, with two families sharing a same mutation, g.ORF15+652-653delAG. All the three ORF15 mutations were first reported in the Japanese population. Affected males showed relatively severe symptoms while female carriers showed a wide spectrum of severity. A tapetal-like reflex was observed in two young females, indicating clinically the carrier status.
CONCLUSIONS: We identified three ORF15 mutations and one RP2 mutation in five Japanese RP families. Moderate or severe myopia might be an indicator for the XLRP status in multiplex RP families which pedigree data are insufficient to allow accurate subtyping. It is suggested that mutational analysis of RPGR and RP2 may help to identify the causative mutation in a proportion of multiplex RP patients with myopia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17093403

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  20 in total

1.  Clinical and genetic characteristics of 14 patients from 13 Japanese families with RPGR-associated retinal disorder: report of eight novel variants.

Authors:  Go Mawatari; Kaoru Fujinami; Xiao Liu; Lizhu Yang; Yu-Fujinami Yokokawa; Shiori Komori; Shinji Ueno; Hiroko Terasaki; Satoshi Katagiri; Takaaki Hayashi; Kazuki Kuniyoshi; Yozo Miyake; Kazushige Tsunoda; Kazutoshi Yoshitake; Takeshi Iwata; Nobuhisa Nao-I
Journal:  Hum Genome Var       Date:  2019-08-02

2.  RP2 phenotype and pathogenetic correlations in X-linked retinitis pigmentosa.

Authors:  Thiran Jayasundera; Kari E H Branham; Mohammad Othman; William R Rhoades; Athanasios J Karoukis; Hemant Khanna; Anand Swaroop; John R Heckenlively
Journal:  Arch Ophthalmol       Date:  2010-07

Review 3.  Gene augmentation for X-linked retinitis pigmentosa caused by mutations in RPGR.

Authors:  William A Beltran; Artur V Cideciyan; Alfred S Lewin; William W Hauswirth; Samuel G Jacobson; Gustavo D Aguirre
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-09       Impact factor: 6.915

4.  Novel TRPM1 mutations in two Chinese families with early-onset high myopia, with or without complete congenital stationary night blindness.

Authors:  Lin Zhou; Tuo Li; Yi-Qiao Xing; Yin Li; Qing-Song Wu; Mao-Ju Zhang
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

5.  Profiling of visual acuity and genotype correlations in RP2 patients: a cross-sectional comparative meta-analysis between carrier females and affected males.

Authors:  Omar Babar Saeed; Elias I Traboulsi; Razek Georges Coussa
Journal:  Eye (Lond)       Date:  2022-01-29       Impact factor: 3.775

6.  Mutations of 60 known causative genes in 157 families with retinitis pigmentosa based on exome sequencing.

Authors:  Yan Xu; Liping Guan; Tao Shen; Jianguo Zhang; Xueshan Xiao; Hui Jiang; Shiqiang Li; Jianhua Yang; Xiaoyun Jia; Ye Yin; Xiangming Guo; Jun Wang; Qingjiong Zhang
Journal:  Hum Genet       Date:  2014-06-18       Impact factor: 4.132

7.  Mutations in RPGR and RP2 account for 15% of males with simplex retinal degenerative disease.

Authors:  Kari Branham; Mohammad Othman; Matthew Brumm; Athanasios J Karoukis; Pelin Atmaca-Sonmez; Beverly M Yashar; Sharon B Schwartz; Niamh B Stover; Karmen Trzupek; Dianna Wheaton; Barbara Jennings; Maria Laura Ciccarelli; K Thiran Jayasundera; Richard A Lewis; David Birch; Jean Bennett; Paul A Sieving; Sten Andreasson; Jacque L Duncan; Gerald A Fishman; Alessandro Iannaccone; Richard G Weleber; Samuel G Jacobson; John R Heckenlively; Anand Swaroop
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

8.  Phenotypic conservation in patients with X-linked retinitis pigmentosa caused by RPGR mutations.

Authors:  Sarwar Zahid; Naheed Khan; Kari Branham; Mohammad Othman; Athanasios J Karoukis; Nisha Sharma; Ashley Moncrief; Mahdi N Mahmood; Paul A Sieving; Anand Swaroop; John R Heckenlively; Thiran Jayasundera
Journal:  JAMA Ophthalmol       Date:  2013-08       Impact factor: 7.389

9.  X-Chromosome Inactivation Is a Biomarker of Clinical Severity in Female Carriers of RPGR-Associated X-Linked Retinitis Pigmentosa.

Authors:  Abigail T Fahim; Lori S Sullivan; Sara J Bowne; Kaylie D Jones; Dianna K H Wheaton; Naheed W Khan; John R Heckenlively; K Thiran Jayasundera; Kari H Branham; Chris A Andrews; Mohammad I Othman; Athanasios J Karoukis; David G Birch; Stephen P Daiger
Journal:  Ophthalmol Retina       Date:  2019-11-18

10.  Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degeneration.

Authors:  Jason Charng; Artur V Cideciyan; Samuel G Jacobson; Alexander Sumaroka; Sharon B Schwartz; Malgorzata Swider; Alejandro J Roman; Rebecca Sheplock; Manisha Anand; Marc C Peden; Hemant Khanna; Elise Heon; Alan F Wright; Anand Swaroop
Journal:  Hum Mol Genet       Date:  2016-12-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.